The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s peptide antibiotics market report forecasts the peptide antibiotics market size to grow to $6.22 Billion by 2027, with a CAGR (compound annual growth rate) of almost 8%.

Learn More On The Peptide Antibiotics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Peptide Antibiotics Market Size Forecast
The global peptide antibiotics market is expected to grow from $4.23 billion in 2022 to $4.58 billion in 2023 at a compound annual growth rate (CAGR) of 8.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The peptide antibiotics market size is expected to grow to $6.22 billion in 2027 at a CAGR of 7.9%.

North America held the largest peptide antibiotics market share.

Key Peptide Antibiotics Market Driver ­– Increase In The Prevalence Of Various Infectious Diseases
According to the Australian Institute of Health and Welfare, an organization that provides data and statistics about Australia’s welfare and health, the number of cases of notifiable infectious diseases in Australia increased from 2.89 million cases in 2020 to 7.02 million cases in 2021 in July 2022. It shows a significant increase in the overall number of infectious disease cases. As a result, the market for peptide antibiotics is growing as the prevalence of infectious diseases rises.

Request for A Sample Of The Global Peptide Antibiotics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Key Peptide Antibiotics Market Trend – Strategic Partnership
Leading peptide antibiotics companies are forming alliances to expand their markets and pool their resources. For example, in January 2022, Berkeley Lights, a US-based company specializing in digital cell biology, partnered with Aanika Biosciences. Aanika will use Berkeley Lights’ high-throughput, functional screening service as part of this collaboration to quickly identify and improve functional antimicrobial peptides (AMPs) that can get rid of harmful bacteria, particularly those that cause outbreaks of foodborne illness. The Beacon Optofluidic Platform will also be used to identify peptides that are harmful to bacteria in order to create a novel antibacterial tag and secure the food supply chain. This will be done to develop a new antibacterial tag that will be used in their bacterial spore-based barcoding technology. Aanika Biosciences is a biotechnology company based in the United States.

Peptide Antibiotics Market Segment
1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-rRibosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP/VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Peptide Antibiotics Market Major Players and Strategies
Major players in the peptide antibiotics market are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Theravance Biopharma, Pacgen Life Science Corporation, Kasten, Savara Pharmaceuticals, Merck KGaA, Madam Therapeutics, Allergan PLC., Dr. Reddy’s Laboratories Ltd., Sanofi, Fresenius Kabi AG, Novo Holdings A/S and Teva Pharmaceutical Industries Ltd.

The Peptide Antibiotics Global Market Report 2023 covers regional data on peptide antibiotics market size, peptide antibiotics market trends and drivers, opportunities, strategies, and peptide antibiotics market competitor analysis. The countries covered in the peptide antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Peptide antibiotics are peptide-based antibiotics that disrupt physical cell membranes to exert antibacterial effects. Peptide antibiotics work by entering bacterial membranes, accumulating within the bacteria, and interfering with their ability to function.

View More Reports Related To The Peptide Antibiotics Market –
Peptide Therapeutics Global Market Report 2023
Veterinary Antibiotics Global Market Report 2023
Anticoagulants Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: